Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia …

O Ozhan, H Parlakpinar, A Acet - Fundamental & Clinical …, 2021 - Wiley Online Library
Myocardial ischemia may occur as a result of pathophysiological and therapeutical
applications such as atherosclerosis, thromboembolism, percutaneous transluminal …
被引用次数：14 相关文章

Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia …

O ÖZHAN, H PARLAKPINAR… - FUNDAMENTAL & …, 2021 - avesis.inonu.edu.tr
Myocardial ischemia may occur as a result of pathophysiological and therapeutical
applications such as atherosclerosis, thromboembolism, percutaneous transluminal …

Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia …

O Ozhan, H Parlakpinar, A Acet - Fundamental & Clinical …, 2020 - europepmc.org
Myocardial ischemia may occur as a result of pathophysiological and therapeutical
applications such as atherosclerosis, thromboembolism, percutaneous transluminal …

Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia …

O Ozhan, H Parlakpinar, A Acet - Fundamental & clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Myocardial ischemia may occur as a result of pathophysiological and therapeutical
applications such as atherosclerosis, thromboembolism, percutaneous transluminal …
[PDF] researchgate.net

[PDF][PDF] Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial …

O Ozhan, H Parlakpinar, A Acet - 2020 - researchgate.net
Myocardial ischemia may occur as a result of pathophysiological and therapeutical
applications such as atherosclerosis, thromboembolism, percutaneous transluminal …